Hair loss is a well-known side effect of many chemotherapy regimens, with many men and women reporting it to be the most traumatic and intense aspect of their cancer treatment. It is estimated that 1 out of 12 patients actually refuse chemotherapy because they do not want to lose their hair. 

The Paxman Cooling System (also known as the 'cold cap') alleviates the damage caused to the hair follicles by chemotherapy. It works by reducing the temperature of the scalp by a few degrees immediately before, during and after the administration of chemotherapy. Liquid coolant passes through the cap extracting heat from the patient's scalp, ensuring the scalp remains at an even, constant temperature to minimize hair loss. 

Scalp cooling provides a proven alternative to hair loss, resulting in a high level of retention or even complete hair preservation, improving patients’ self-confidence and creating positive attitudes towards treatment. 

The Paxman Scalp Cooling System is the world-leading hair loss prevention system for chemotherapy patients. It has been used by over 100,000 patients in 35 countries and is responsible for helping patients to keep their hair and retain a feeling of normality during chemotherapy. This scalp cooling system is now available for the first time in Malaysia and is giving Malaysians a choice against hair loss during cancer treatment. There is no more grieving of hair loss during cancer treatment. 

The PAXMAN Scalp Cooling System has been indicated clinically by FDA to reduce the likelihood of chemotherapy-induced hair loss in cancer patients with solid tumours such as: breast , ovarian, colorectal, bowel and prostate cancer.